Japan's Nitto Denko said this week that it has acquired Massachusetts-based nucleic acid manufacturer Avecia Biotechnology.
Terms of the acquisition were not disclosed.
The deal, Nitto Denko said, represents “a significant commitment … to the nucleic acids drug industry.” The company recently forged a collaboration with Quark Pharmaceuticals to develop siRNA-based drugs for fibrotic diseases (GSN 7/15/2010).